A new case report, published in the journal Clinical Case Reports and available online through the National Institutes of Health, suggests that psilocybin may offer a promising treatment option for patients with Complex Regional Pain Syndrome (CRPS).
The study was conducted by researchers from Johns Hopkins University School of Medicine, the University of California San Diego, REMAP Therapeutics Astoria, and New York University, with the title Refractory CRPS pain treated with psilocybin: A case report.
CRPS is a debilitating neuropathic condition often triggered by trauma but can also occur spontaneously. It is characterized by severe, persistent pain and various other symptoms, such as temperature fluctuations, skin discoloration, and muscle weakness. Conventional treatments for CRPS, including medications and invasive procedures like spinal cord stimulation, are often ineffective, leading to a growing interest in alternative therapies like psychedelics.
Continue reading